Clinical practice guidance for juvenile dermatomyositis (JDM) 2018-Update ()

被引:6
|
作者
Kobayashi, Ichiro
Akioka, Shinji
Kobayashi, Norimoto
Iwata, Naomi
Takezaki, Shunichiro
Nakaseko, Haruna
Sato, Satoshi
Nishida, Yutaka
Nozawa, Tomo
Yamasaki, Yuichi
Yamazaki, Kazuko
Arai, Satoru
Nishino, Ichizo
Mori, Masaaki
机构
[1] Center for Pediatric Allergy and Rheumatology, KKR Sapporo Medical Center, Sapporo
[2] Department of Pediatrics, Kyoto Prefectural University of Medicine, Kyoto
[3] Department of Pediatrics, Shinshu University School of Medicine, Matsumoto
[4] Department of Infection and Immunology, Aichi Children’s Health and Medical Center, Obu
[5] Department of Pediatrics, Hokkaido University Hospital, Sapporo
[6] Division of Infectious Disease and Immunology, Saitama Children’s Medical Center, Omiya
[7] Department of Pediatrics, School of Medicine, Gunma University, Maebashi
[8] Department of Pediatrics, School of Medicine, Yokohama City University, Yokohama
[9] Department of Pediatrics, Kagoshima University Hospital, Kagoshima
[10] Department of Pediatrics, Saitama Medical Center, Saitama Medical University, Kawagoe
[11] Department of Dermatology, St. Luke’s International Hospital, Tokyo
[12] Department of Neuromuscular Research, National Institute of Neuroscience, National Center of Neurology and Psychiatry, Tokyo
[13] Lifetime Clinical Immunology, Tokyo Medical and Dental University, Tokyo
关键词
Diagnosis; interstitial lung disease; management; myositis-specific autoantibodies; pathophysiology;
D O I
10.1080/14397595.2020.1764723
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Juvenile dermatomyositis is the most common type of juvenile idiopathic inflammatory myopathy mainly affecting the skin and proximal muscles. We have published the Japanese version of ‘Clinical practice guidance for juvenile dermatomyositis (JDM) 2018 ‘consisting of a review of articles in the field and evidence-informed consensus-based experts’ opinion on the treatment strategy in collaboration with The Pediatric Rheumatology Association of Japan and The Japan College of Rheumatology under the financial support by ‘Research on rare and intractable diseases, Health and Labor Sciences Research Grants’. This article is a digest version of the Japanese guidance. © 2019, © 2019 Japan College of Rheumatology. Published by Informa UK Limited, trading as Taylor & Francis Group.
引用
收藏
页码:607 / 607
页数:1
相关论文
共 50 条
  • [1] Clinical characteristics of 102 children with juvenile dermatomyositis (JDM).
    Ramanan, AV
    Tse, S
    Parker, S
    Schneider, R
    Silverman, ED
    Laxer, RM
    Feldman, BM
    ARTHRITIS AND RHEUMATISM, 2002, 46 (09): : S308 - S308
  • [2] Calcinosis as a complication of juvenile dermatomyositis (JDM)
    Malagón Clara
    Yépez Ricardo
    Contreras Luz
    Pediatric Rheumatology, 9 (Suppl 1)
  • [3] Juvenile dermatomyositis (JDM) sine myositis
    C Schuetz
    V Mohr
    C Pfeiffer
    A Schulz
    KM Debatin
    Pediatric Rheumatology, 9 (Suppl 1)
  • [4] JOINT INVOLVEMENT IN JUVENILE DERMATOMYOSITIS (JDM)
    Malagon, Clara
    Jimenez, Karen
    JCR-JOURNAL OF CLINICAL RHEUMATOLOGY, 2019, 25 : S71 - S72
  • [5] Update on the clinical management of juvenile dermatomyositis
    Huber, Adam M.
    EXPERT REVIEW OF CLINICAL IMMUNOLOGY, 2018, 14 (12) : 1021 - 1028
  • [6] Clinical practice guidance for juvenile idiopathic arthritis (JIA) 2018
    Okamoto, Nami
    Yokota, Shumpei
    Takei, Syuji
    Okura, Yuka
    Kubota, Tomohiro
    Shimizu, Masaki
    Nozawa, Tomo
    Iwata, Naomi
    Umebayashi, Hiroaki
    Kinjo, Noriko
    Kunishima, Tomoko
    Yasumura, Junko
    Mori, Masaaki
    MODERN RHEUMATOLOGY, 2019, 29 (01) : 41 - 59
  • [7] Use of etanercept in chronic juvenile dermatomyositis (JDM).
    Miller, ML
    Smith, RL
    Abbott, KA
    Sinacore, JM
    Pachman, LM
    ARTHRITIS AND RHEUMATISM, 2002, 46 (09): : S306 - S306
  • [8] Multicentre study of outcome in juvenile dermatomyositis (JDM)
    Huber, AM
    Lang, B
    LeBlanc, CMA
    Birdi, N
    MacNeil, J
    Feldman, BM
    ARTHRITIS AND RHEUMATISM, 1998, 41 (09): : S264 - S264
  • [9] Risk factors of calcinosis in juvenile dermatomyositis(JDM).
    Sallum, AME
    Pivato, FC
    Paim, LB
    Leone, C
    Liphaus, BL
    Silva, CAA
    ARTHRITIS AND RHEUMATISM, 2003, 48 (09): : S513 - S513
  • [10] The Association Between Gingival Inflammation and Clinical Signs of Active Juvenile Dermatomyositis (JDM)
    Chow, Albert
    Song, Hyun
    Brenchley, Laurie
    Bayat, Nastaran
    Eckert, Mary
    Koester, Sean
    Schiffenbauer, Adam
    Volochayev, Rita
    Gardner, Pamela
    Lee, Peggy
    McLean, Jeffrey
    Shenoi, Susan
    Rider, Lisa
    Stevens, Anne
    Dey, Neelendu
    ARTHRITIS & RHEUMATOLOGY, 2023, 75 : 2388 - 2389